HB 1228 South Dakota House · 2022 Regular Session

expand the ability for patients to seek investigational drugs, biological products, or devices.

Bill status failed 3 of 5 stages cleared
Introduction
Feb 2022
Committee Review
Mar 2022
House Passage
Feb 2022
Senate Failed
Mar 2022
Governor
Introduced Feb 23, 2022 Last action Mar 7, 2022
Floor votes · Senate Mar 7, 2022 · House Feb 23, 2022

How they voted

623
Failed · 3 other
Total votes 32
Mar 7, 2022
D Democratic3
3
0% Nay
R Republican29
6 Yea 23 Nay
79% Nay
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
12
Key actions
3
Committee
4
Mar 7, 2022
Vote failed
Senate Vote: fail (6-23-3)
senate
Mar 2, 2022
Upper · Passed
Health and Human Services Do Pass , Passed, YEAS 4, NAYS 3 S.J. 1
upper
Feb 28, 2022
Committee
Health and Human Services Do Pass , Passed, YEAS 3, NAYS 2
upper
Feb 23, 2022
Introduced
First read in Senate and referred to S.J. 329
upper
Feb 23, 2022
Lower · Passed
House of Representatives Do Pass , Passed, YEAS 57, NAYS 13 H.J. 441
lower
Feb 22, 2022
Lower · Passed
Health and Human Services Do Pass , Passed, YEAS 9, NAYS 1
lower
Jan 31, 2022
Committee
Referred to H.J. 156
lower
7 primary · 0 co-sponsors

Sponsors